A prospective randomized study using adjuvant locoregional chemoimmunotherapy in combination with surgery for pancreatic carcinoma

Hepato-Gastroenterology

Volumn 45, Issue 24, 1998, Pages 2376-2381

  Lygidakis, N J ^a   Berberabe, A E ^a   Spentzouris, N ^a   Dedemadi, G ^a   Kalligas, T ^a   Loukas, G ^a   Sotiropoulou, V ^a  

^a ATHENS MEDICAL CENTER   (Greece)

Author keywords

Adjuvant targeted locoregional chemoimmunotherapy; Interleukin 2; Pancreatic carcinoma; Transplenic immunostimulation; Transtumoral immunostimulation

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; GAMMA INTERFERON; GEMCITABINE; IMMUKIN; INTERLEUKIN 2; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MITOXANTRONE; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MITOXANTRONE; PALLIATIVE CARE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032431738     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Johnson R: Pancreatic cancer. Hepato-Gastroenterol 1995; 42:294-297.
2. Crist DW, Sitzmann JV, Cameron JL: Improved hospital morbidity, mortality and survival after Whipple procedure. Ann Surg 1987; 206:358-365.
3. Kimura W: Duct-ectatic type of mucin-producing tumor of the pancreas - New concept of pancreatic neoplasia. Hepato-Gastroenterol 1996; 43:692-703.
4. Ishii H: CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer. Hepato-Gastroenterol 1997; 44:279-283.
5. Ishikawa O: Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepato-Gastroenterol 1996; 43:320-325.
6. Lygidakis NJ: Pancreatic surgery today. Hepato-Gastroenterol 1996; 43:779-784.
7. Lygidakis NJ: Reconstruction of alimentary continuity after subtotal duodenopancreatectomy. Hepato-Gastroenterol 1996; 43:971-979.
8. Lygidakis NJ: Regional vascular resection for pancreatic head carcinoma. Hepato-Gastroenterol 1996; 43:1327-1333.
9. Fennely D: The role of chemotherapy in the treatment of adenocarcinoma of the pancreas. Hepato-Gastroenterol 1996; 43:356-362.
10. Horimi T: The beneficial effect of tamoxifen therapy in patients with resected adenocarcinoma of the pancreas. Hepato-Gastroenterol 1996; 43:1225-1229.
11. Hosotani R: Results of pancreatectomy with radiation therapy for pancreatic cancer. Hepato-Gastroenterol 1997; 44:1528-1535.
12. Ishikawa O: Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepato-Gastroenterol 1997; 44:1541-1546.
13. Lygidakis NJ: Unresectable pancreatic cancer: Is a multi modality approach a promising therapeutical alternative? Hepato-Gastroenterol 1997; 44:1222-1228.
14. Shibamoto Y: Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer. Hepato-Gastroenterol 1996; 43:326-332.
15. Boldrini E: A difficult early diagnosis of pancreatic body neoplasia. Hepato-Gastroenterol 1996; 43:730-733.
16. Nakao A: Intraoperative radiotherapy for pancreatic carcinoma with hepatic or peritoneal metastases. Hepato-Gastroenterol 1997; 44:1469-1471.
17. Takahashi T: Predictive factors for long-term survival in patients with pancreatic carcinoma. Hepato-Gastroenterol 1997; 44:1463-1468.
18. Jeekel J: Medical treatment for pancreatic carcinoma. In: Pitfalls and complications in the diagnosis and management of hepatobiliary and pancreatic diseases. Lygidakis NJ and Makuuchi M (Eds.). Thieme Med Publishers Inc. 1996; pp. 451-453.
19. Pretre R, Hubert O, Robert J: Results of surgical palliation for cancer of the head of the pancreas and periampullary region. Br J Surg 1992; 79:795-798.
20. Muchmore J: Regional chemotherapy with hemofiltration. A rationale for a different treatment approach to advanced pancreatic cancer. Hepato-Gastroenterol 1996; 43:346-355.
21. Ohigashi H: A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepato-Gastroenterol 1996; 43:338-345.
22. Balladur P: Bleeding of the pancreatic stump following pancreaticoduodenectomy. Hepato-Gastroenterol 1996; 43:268-270.
23. Launois B: La chirurgie du pancreas pour cancer. Bordeaux Med 1983; 17:115-118.
24. Cullinan S, Moertel CG, Wieand HS, et al: A phase III trial on the therapy of advanced pancreatic carcinoma. Cancer 1990; 65:2201-2212.
25. Fennely D, Kelsen D: The role of chemotherapy in the treatment of adenocarcinoma of the pancreas. Hepato-Gastroenterol 1996; 43:356-362.
26. Nakagawa T, Ueno K, Tawara T, et al: Evaluation of long term survivors after pancreatoduodenectomy for pancreatoduodenal carcinoma. Hepato-Gastroenterol 1995; 42:1039-1052.
27. Lygidakis NJ, Stringaris K: Locoregional chemoimmunotherapy transplenic and transtumoral in vivo immunostimulation. Hepato-Gastroenterol 1996; 43:440-447.
28. Lygidakis NJ, Spentzouris N, Theodorakopoulos, et al: Pancreatic resection for pancreatic carcinoma combined with now- and adjuvant locoregional targeting immunochemotherapy - a prospective randomized study. Hepato-Gastroenterol 1998; 45:396-405.